Prescription Drug Price Transparency: The Compliance Requirements Self-Insured Employers Are Missing

Self-insured employers are navigating a maze of overlapping federal disclosure requirements for prescription drug pricing. Unlike fully insured plans, self-insured plans bear the risk directly, which means regulators are watching more closely. The Department of Labor (DOL), Department of Health and Human Services (HHS), and Department of Treasury have all issued separate rules that apply simultaneously—and they don't align perfectly.

The Core Transparency Rules and Your Deadlines

The 2024 Drug Pricing Rule (CMS/HHS)

The Centers for Medicare & Medicaid Services finalized rules in 2023 requiring health plans to report drug prices and rebates. This rule applies directly to self-insured plans.

What you must disclose:

• Net drug prices (after rebates) for medications that cost more than $30 per unit or $100 per month in total expenditures
• Rebate amounts by drug and by therapeutic class
• Pharmacy benefit manager (PBM) fees and incentive arrangements
• Price increases and decreases year-over-year

Deadline: Reporting is due annually to CMS by March 31 for the prior calendar year. The first reporting cycle under the final rule occurred in March 2024.

Who sees it: CMS publishes this data publicly, with limited protections for proprietary information. Your plan's drug spending, rebate practices, and PBM arrangements will be visible to competitors and regulators.

DOL Form 5500 Requirements

The Department of Labor requires self-insured health plans to file Schedule H on Form 5500. This expanded requirement now includes specific pharmacy benefit data.

Current disclosure requirements:

• Pharmacy benefit service charges (in dollars, not percentages)
• Breakdown of rebates retained by PBMs versus passed to plans
• Prescription drug utilization trends

Deadline: Annual Form 5500 filing by the plan's tax deadline plus 8.5 months (typically July for calendar-year plans).

The gap: The DOL's requirements are less granular than CMS's rule, but violations trigger audit risk and potential penalties of $4,000+ per day per failure.

The Transparency in Coverage Rule (Effective 2022)

This CMS rule requires plans to make pricing information available to members in real time through a machine-readable file and an online tool.

What applies to self-insured plans:

• Real-time cost estimates for specific drugs at specific pharmacies
• Negotiated rates for in-network providers
• Out-of-pocket maximums and deductible tracking

Deadline: The machine-readable file must be updated monthly; the online tool requires response within one business day of a member query.

Enforcement tightening: CMS has cited plans for inaccurate pricing data and stale rate files. Self-insured plans have been issued 4,000+ notices of non-compliance since 2023.

ERISA Plan Documents and Participant Disclosures

Federal ERISA rules require self-insured plans to maintain accurate plan documents describing pharmacy benefit terms. This includes:

• Drug formulary changes and the effective date
• Prior authorization and step-therapy protocols
• In-network versus out-of-network pharmacy benefits
• PBM compensation methods (direct fees, rebates, spread pricing)

Deadline: Updated plan documents must reflect changes within 120 days of implementation. Participant summaries of material modifications must be distributed within 60 days.

Where Self-Insured Employers Are Failing

Fragmented Data Systems

CMS, DOL, and internal compliance teams often use different data definitions. Self-insured plans report rebate information three different ways across three different agencies, creating reconciliation nightmares.

Real impact: A mid-market self-insured plan with 5,000 employees spends 400+ hours annually reconciling pharmacy data across reporting systems. Discrepancies between CMS and DOL filings have triggered audits.

PBM Opacity

Many self-insured plans contract with PBMs using spread pricing or opaque rebate arrangements that obscure net costs. CMS rules now require disclosure of these amounts, but 35% of self-insured plans report they cannot fully isolate PBM fees from rebate pass-through percentages.

Why it matters: If your plan can't accurately report what the PBM retains versus passes back, you're out of compliance with CMS reporting and potentially violating fiduciary duty to your participants.

Stale Pricing Files

The Transparency in Coverage machine-readable file must reflect current negotiated rates. Self-insured plans often rely on year-old rate files or aggregated data that doesn't match individual pharmacy contracts.

Enforcement trend: CMS has fined plans $500+ per day for files that don't update within 30 days of contract changes.

Missing Plan Document Updates

Self-insured plans often fail to update plan documents when pharmacy benefits change. Adding a new PBM, changing formulary management, or shifting to reference-based pricing requires prompt disclosure to participants.

Compliance gap: 22% of self-insured plans lack formal processes to review and update plan documents after pharmacy contract changes.

The Compliance Cost

Achieving full compliance requires:

• Dedicated personnel or vendor support to reconcile three separate regulatory frameworks ($50,000–$150,000 annually for plans with 3,000+ employees)
• Technical infrastructure to generate accurate, timely machine-readable files ($30,000–$80,000 initial implementation)
• Quarterly audits of pharmacy data accuracy ($15,000–$40,000 annually)
• Legal review of PBM contracts and plan documents ($10,000–$25,000 annually)

Non-compliance carries real consequences: audit notices from DOL, public reporting of incomplete or inaccurate data, participant litigation under ERISA, and potential penalties.

Bottom Line

Audit your current pharmacy reporting now. Specifically:

1. Map your data flows. Identify which systems feed CMS, DOL, and internal compliance—and where definitions diverge.
2. Verify PBM transparency. Demand itemized reporting of what your PBM retains versus passes back. This is now non-negotiable for compliance.
3. Validate your pricing files. Run a sample check of your Transparency in Coverage machine-readable file against actual claims data from the past 90 days.
4. Update your plan documents. Schedule a formal review within the next 60 days with your attorney and benefits team.

The regulatory environment around drug pricing transparency is tightening, not loosening. Self-insured plans that lack systems to track and report accurately now will face higher remediation costs later.